tiprankstipranks
Microbot Medical Inc (MBOT)
NASDAQ:MBOT

Microbot Medical Stock Price & Analysis

533 Followers

MBOT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$4.31 - $9.60
Previous Close$4.98
Volume15.06K
Average Volume (3M)9.90K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$9.29M
Total Debt (Recent Filing)$443.00K
P/E Ratio-2.7
Beta0.65
Next EarningsMar 31, 2021
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)-1.84
Shares Outstanding7,108,133
R-Squared0.09
Standard Deviation0.60
10 Day Avg. Volume16,696
30 Day Avg. Volume9,904
P/B Ratio4.15
P/S RatioN/A
P/CF RatioN/A
P/FCF Ratio-3.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside301.61% Upside
Rating ConsensusModerate Buy
Alpha0.02
Number of Analyst Covering1


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

MBOT FAQ

What was Microbot Medical’s price range in the past 12 months?
Microbot Medical lowest stock price was $4.31 and its highest was $9.60 in the past 12 months.
    What is Microbot Medical’s market cap?
    Currently, no data Available
    When is Microbot Medical’s upcoming earnings report date?
    Microbot Medical’s upcoming earnings report date is Mar 31, 2021 which is 544 days ago.
      How were Microbot Medical’s earnings last quarter?
      Microbot Medical released its earnings results on Apr 14, 2020. The company reported -$0.31 earnings per share for the quarter, missing the consensus estimate of -$0.28 by -$0.03.
        Is Microbot Medical overvalued?
        According to Wall Street analysts Microbot Medical’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Microbot Medical pay dividends?
          Microbot Medical does not currently pay dividends.
          What is Microbot Medical’s EPS estimate?
          Microbot Medical’s EPS estimate is -$0.34.
            How many shares outstanding does Microbot Medical have?
            Microbot Medical has 7,108,133 shares outstanding.
              What happened to Microbot Medical’s price movement after its last earnings report?
              Microbot Medical reported an EPS of -$0.31 in its last earnings report, missing expectations of -$0.28. Following the earnings report the stock price went up 0.71%.
                Which hedge fund is a major shareholder of Microbot Medical?
                Currently, no hedge funds are holding shares in MBOT

                ---

                Microbot Medical Stock Analysis

                Smart ScoreNeutral
                1
                2
                3
                4
                5
                6
                7
                8
                9
                10
                6
                The Microbot Medical stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Microbot Medical Inc

                Microbot Medical, Inc. is a pre-clinical medical device company, which engages in the research, design, development, and commercialization of micro-robotics assisted medical technologies. The firm carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system, and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Abbott Labs
                Intuitive Surgical
                Stryker
                Becton Dickinson
                Edwards Lifesciences

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis